Skip to main content
SpringerLink
Log in

How useful are combinations of blood tests in “Rheumatic panels” in diagnosis of rheumatic diseases?

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Laboratory tests are sometimes combined into “panels,” presumably to facilitate a swift and accurate diagnosis. “Rheumatic panels” were available from 16 of 17 members of the American Clinical Laboratory Association. Panels included an average of five tests (range three to 11). Panel prices ranged from $25 to $189. The three tests most common in the available panels were those for rheumatoid factor, antinuclear antibody, and uric acid level. A panel combining these three tests would have a positive predictive value of only 34.6% in identifying rheumatoid arthritis, systemic lupus erythematosus, or gout in a population with joint pain, in which the combined prevalence of these diseases is estimated to be 10%. Therefore, 65.4% of persons with a “positive” test would not have one of these three rheumatic diseases. Lack of independence between diseases and second tests (for example, positive antinuclear antibodies in rheumatoid arthritis) increases misclassification errors. A careful history and physical examination along with serial ordering of a few selected tests appear optimal to establish a clinical diagnosis of a rheumatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rose HM, Ragan C, Pearce E, Lipman MO. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1948;68:1–6.

    Google Scholar 

  2. Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 1957;126:162–3.

    Article  PubMed  CAS  Google Scholar 

  3. Wyngaarden JB, Kelley WN. Gout and hyperuricemia. New York: Grune and Stratton, 1976.

    Google Scholar 

  4. Cebul RD, Beck JR. Biochemical profiles: applications in ambulatory screening and preadmission testing of adults. Ann Intern Med 1987;106:403–13.

    PubMed  CAS  Google Scholar 

  5. Valkenburg HA, Ball J, Burch TA, Bennett PH, Lawrence JS. Rheumatoid factors in a rural population. Ann Rheum Dis 1966;26:497–507.

    Google Scholar 

  6. Mikkelson WM, Dodge HJ, Duff IF, Kato H. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959–60. J Chronic Dis 1967;20:351–369.

    Article  Google Scholar 

  7. Wolfe AM. The epidemiology of rheumatoid arthritis: a review. Part I, Surveys: Part II, Incidence and diagnostic criteria. Bull Rheum Dis 1968;19:518–529.

    PubMed  CAS  Google Scholar 

  8. Linos A, Worthington JW, O’Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87–98.

    PubMed  CAS  Google Scholar 

  9. Allander E. The prevalence of rheumatoid arthritis: present knowledge and some future directions of research. In: Lawrence RC, Shulman LE, eds. Epidemiology of the rheumatic diseases. New York: Gower Medical Publishing, 1984;127–31.

    Google Scholar 

  10. Harris ED. Rheumatoid arthritis: the clinical spectrum. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed. Philadelphia: W. B. Saunders, 1985;915–50.

    Google Scholar 

  11. Williams RC, McCarty DJ. Clinical picture of rheumatoid arthritis, In: McCarty DJ, ed. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger, 1985;605–42.

    Google Scholar 

  12. Merrell M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1955;1:12–32.

    Article  PubMed  CAS  Google Scholar 

  13. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50:85–95.

    Article  PubMed  CAS  Google Scholar 

  14. Masi AT. Clinical epidemiologic perspective of systemic lupus erythematosus. In: Lawrence RC, Shulman LE, eds. Epidemiology of the rheumatic diseases. New York: Gower Medical Publishing, 1984;145–63.

    Google Scholar 

  15. Rothfield N. Systemic lupus erythematosus: clinical aspects and treatment. In: McCarty DJ, ed. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger, 1985;911–35.

    Google Scholar 

  16. Rothfield N. Clinical features of systemic lupus erythematosus. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed. Philadelphia: W. B. Saunders, 1985;1070–97.

    Google Scholar 

  17. Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967;42:27–37.

    Article  PubMed  CAS  Google Scholar 

  18. Wyngaarden JB, Kelley WN. Gout. In: Stanbury JB, Wyngarten JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw Hill, 1982;1043–114.

    Google Scholar 

  19. Hawthorne VM. The epidemiology of gout and pseudogout. In: Lawrence RC, Shulman LE, eds. Epidemiology of the rheumatic diseases. New York: Gower Medical Publishing, 1984;244–60.

    Google Scholar 

  20. Kelley WN, Fox IH. Gout and related disorders of purine metabolism. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed. Philadelphia, W. B. Saunders, 1985;1359–98.

    Google Scholar 

  21. Holmes EW. Clinical gout and the pathogenesis of hyperuricemia. In: McCarty DJ, ed. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger, 1985;1445–80.

    Google Scholar 

  22. Carson DA. Rheumatoid factor. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed.. Philadelphia, W. B. Saunders, 1985;664–79.

    Google Scholar 

  23. Reichlin M. Antinuclear antibodies. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed. Philadelphia: W. B. Saunders, 1985;690–707.

    Google Scholar 

  24. Tan EM. Systemic lupus erythematosus: immunologic aspects. In: McCarty DJ, ed. Arthritis and allied conditions. 10th ed. Philadelphia: Lea & Febiger, 1985;936–41.

    Google Scholar 

  25. Richardson B, Epstein WV. Utility of the fluorescent antibody test in a single patient. Ann Intern Med 1981;95:333–8.

    PubMed  CAS  Google Scholar 

  26. Wortman RL. Management of hyperuricemia. In: McCarty DJ, ed. Arthritis and allied conditions. Tenth edition. Philadelphia: Lea & Febiger, 1985;1481–93.

    Google Scholar 

  27. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 1980;59:239–48.

    Article  PubMed  CAS  Google Scholar 

  28. Cebul RD, Hershey JC, Williams SV. Using multiple tests: series and parallel approaches. Clin Lab Med 1982;2:871–800.

    PubMed  CAS  Google Scholar 

  29. Kelsey JL. Epidemiology of musculoskeletal diseases. New York: Oxford University Press, 1982.

    Google Scholar 

  30. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnosis. New York: John Wiley and Sons, 1975.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, Room 2553, The Vanderbilt Clinic, Department of Medicine, Vanderbilt University, 37232, Nashville, TN

    Michael J. Lichtenstein MD, MSc

Authors
  1. Michael J. Lichtenstein MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore Pincus MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from the Division of General Internal Medicine, Department of Medicine, and the Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Supported in part by the Robert Wood Johnson Foundation and the Jack C. Massey Foundation. Dr. Lichtenstein is a Milbank Memorial Fund Scholar in Clinical Epidemiology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lichtenstein, M.J., Pincus, T. How useful are combinations of blood tests in “Rheumatic panels” in diagnosis of rheumatic diseases?. J Gen Intern Med 3, 435–442 (1988). https://doi.org/10.1007/BF02595919

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02595919

Key words

Search

Navigation